‘Smart-bomb’ to target cancer, evade body’s immune system
The HinduScientists have inched closer to a nanotechnology therapy that targets cancer with a “Stealth smart bomb” tuned to dodge the body’s immune system. BIND 014, which targets tumour cells while evading the body’s immune system, promises to deliver larger and more effective doses of drugs to cancers, while simultaneously sparing patients many of the distressing side—effects of chemotherapy, The Times newspaper said today. “Regular nanoparticles struggle to get through to tumours,” said Professor Robert Langer, of the Massachusetts Institute of Technology, who developed the “special delivery parcel” along with and Omid Farokhzad of Harvard University. “We’ve created a nanoparticle decorated with two molecules, one of which helps it to dodge the immune system, while the other helps it to target cancer cells,” Professor Langer was quoted as saying by the British daily.
History of this topic
Human trials start with cancer treatment that primes immune system to kill off tumours
The IndependentDiscover Related